Since the known molecular mechanisms by which metformin (insulin sensitizer) and canagliflozin (causing glucosuria) exert their glucose lowering effects are completely different, a possible synergistic effect on DKD development could not be excluded [46]. The gene discussed is INS; the disease is diabetic kidney disease.